Re-evaluating sarcoplasmic reticulum function in heart failure.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed.

1. Microarray analysis of active cardiac remodeling genes in a familial hypertrophic cardiomyopathy mouse model rescued by a phospholamban knockout.Physiological genomics · 2013
   Article
2. Long-term rescue of a familial hypertrophic cardiomyopathy caused by a mutation in the thin filament protein, tropomyosin, via modulation of a calcium cycling protein.Journal of molecular and cellular cardiology · 2011
   Article
3. Gene therapy targets in heart failure: the path to translation.Clinical pharmacology and therapeutics · 2011
   Review
4. Two close, too close: sarcoplasmic reticulum-mitochondrial crosstalk and cardiomyocyte fate.Circulation research · 2010
   Review
5. Rescue of familial cardiomyopathies by modifications at the level of sarcomere and Ca2+ fluxes.Journal of molecular and cellular cardiology · 2010
   Review
6. Beta-adrenergic stimulation and myocardial function in the failing heart.Heart failure reviews · 2009
   Review
7. Endoplasmic reticulum-mitochondria crosstalk in NIX-mediated murine cell death.The Journal of clinical investigation · 2009
   Article
8. Gene therapy in heart failure.Circulation research · 2008
   Review
9. Altered intracellular Ca2+ handling in heart failure.The Journal of clinical investigation · 2005
   Review
10. Rescue of cardiomyocyte dysfunction by phospholamban ablation does not prevent ventricular failure in genetic hypertrophy.The Journal of clinical investigation · 2003
    Article

Corrections and comments

• Comment on
  Meeting Koch's postulates for calcium signaling in cardiac hypertrophy.2000

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as